Guardant Health GH
NASDAQ GH
$182.99 +8.09 (+4.63%)
As of: Sep 17, 2026 · 3:59 PM EDT

Guardant Health (GH) Deferred Taxes (2019)

Guardant Health's (GH) quarterly Deferred Taxes came in at -$2.8 million in Q4 2019.

Analysis

Guardant Health (GH) Deferred Taxes (2019) Analysis & Trends

Guardant Health has disclosed Deferred Taxes across 1 years of filings, most recently posting -$2.8 million for Q4 2019.

  • In Q4 2019, Deferred Taxes changed N/A year-over-year to -$2.8 million; the TTM figure through Dec 2020 stood at -$2.8 million (changed 0.0% YoY), while the FY2022 annual figure was $99.8 million, changed N/A from the prior year.
  • Deferred Taxes came in at -$2.8 million for Q4 2019 at Guardant Health.
  • In the past five years, Deferred Taxes ranged from a high of -$2.8 million in Q4 2019 to a low of -$2.8 million in Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn -
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn -2.00 Mn
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn -24.40 Mn
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn -
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn -
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn -
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn 9.63 Mn
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn -
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn -
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -2.83 Mn